Ronald R. Blanck, Director at TENAX THERAPEUTICS, INC. (TENX), bought 12,950 shares at $0.46 ($6K) on 2017-12-18, disclosed to the SEC on 2017-12-20.
Open-market purchase of $6k TENX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.45 | 6,475 | $3K | 49.5% |
| 2 | $0.46 | 6,475 | $3K | 50.5% |
| Total | $0.46 avg | 12,950 | $6K | 100% |
| Filing → |
| TENX | BUY | 2015-11-19 | $6K | — | Filing → |
| TENX | BUY | 2015-11-19 | $15K | — | Filing → |
| TENX | BUY | 2015-01-20 | $7K | — | Filing → |